A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.

Phase 3 Unknown 396 enrolled Yi Feng, MD

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study was to evaluate the efficacy and safety of intravenously administered ibuprofen 400mg and 800 mg q6h for the management of moderate to severe postoperative pain in Chinese population.

Timeline

Start: 2020-06-10
Primary completion: 2020-06-10
Completion: 2020-06-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ibuprofen	Small molecule	400 mg	Intravenous
Subject	Ibuprofen	Small molecule	800 mg	Intravenous

Indications

No indication recorded.